NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITY
申请人:ALMIRALL, S.A.
公开号:US20150329535A1
公开(公告)日:2015-11-19
The present invention relates to novel compounds having β2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
本发明涉及具有β2肾上腺素受体激动剂和M3胆碱能受体拮抗剂双重活性的新化合物,以及含有它们的制药组合物,其制备方法及其在呼吸疗法中的使用。